MS News that Caught My Eye Last Week: Gilenya Generics, MS Pain and Fatigue Toolkit, Profit Drives MS Meds Prices, MS and Sugar Link
FDA Approves Three Generic Versions of Novartisā Gilenya for Treating Relapsing MS It’s always nice to hear about generics becoming available to replace expensive multiple sclerosis treatments. But I wonder whether these generics will cost less than the brand-name medication. Will their availability help to drive down the price…